Search Result "everolimus."
mTOR as a Target of Everolimus in Refractory/Relapsed Hodgkin Lymphoma
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 7 Year: 2012 Page: 945-954
Author(s): A. Guarini, C. Minoia, M. Giannoccaro, A. Rana, A. Iacobazzi, A. Lapietra, A. Raimondi, N. Silvestris, C. D. Gadaleta, G. Ranieri
Comparison of Biolimus Versus Everolimus for Drug-Eluting Stents in the Percutaneous Treatment of Infra-Inguinal Arterial Disease
Journal: Current Vascular Pharmacology
Volume: 15 Issue: 3 Year: 2017 Page: 257-264
Author(s): Arturo Giordano,Paolo Ferraro,Nicola Corcione,Stefano Messina,Gennaro Maresca,Enrico Coscioni,Raffaella Avellino,Gabriele Giordano,Mariangela Peruzzi,Antonino G. M. Marullo,Giovanni Napolitano,Maria Fiammetta Romano,Giuseppe Biondi-Zoccai
Clinical Studies with Sirolimus, Zotarolimus, Everolimus and Biolimus A9 Drug- Eluting Stent Systems
Journal: Current Pharmaceutical Design
Volume: 16 Issue: 3 Year: 2010 Page: 4012-4024
Author(s): Bimmer E. Claessen, Jose P.S. Henriques, George D. Dangas
Therapeutic Implications of mTOR Inhibitors in the Treatment of Gastric Cancer
Journal: Current Cancer Drug Targets
Volume: 13 Issue: 2 Year: 2013 Page: 121-125
Author(s): Zhaode Bu, Jiafu Ji
Platelet Reactivity in Patients with Coronary Stenting Treated with Dual Antiplatelet Therapy and after Withdrawal of Clopidogrel: Impact of Bioactive Titanium Stent versus Everolimus-coated Stent
Ebook: Recent Advances in Alzheimer Research
Volume: 4 Year: 2019
Author(s): Amparo Hernandiz,Jose Luis Díez,Antonio Moscardo,Ana Latorre,Maria Dolores Domenech,Maria Teresa Santos,Juana Valles
Doi: 10.2174/97816810839951180401
Targeting mTOR Pathways in Human Malignancies
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 19 Year: 2012 Page: 2766-2777
Author(s): Angelica Fasolo,Cristiana Sessa
Effects of Broad Spectrum Antibiotics on Measurement of Immunosuppressant Drugs
Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 20 Issue: 1 Year: 2021 Page: 101-105
Author(s): Ataman Gönel,Idris Kirhan
High-dose Everolimus May Induce Pro-inflammatory/Fibrotic TranscriptomicChanges in Bronchial Epithelial Cells from Cystic FibrosisPatients
Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 18 Issue: 2 Year: 2021 Page: 91-106
Author(s): Simona Granata,Alberto Verlato,Valentina Masola,Amedeo Carraro,Gloria Santoro,Gianluigi Zaza